Cipla's Q3 net profit rises 49 pc to Rs 1,575 crore, revenue up 7 pc Mumbai, Jan 28: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from Rs ...
Indian Pharma Industry to see negative volume growth in 3Q 2025, but will maintain strong gross margins: Report New Delhi, January 13: The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of modest positive growth, according to Goldman Sachs re...
